Armata Pharmaceuticals, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
ARMP on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
5005 Mcconnell Ave, Los Angeles, California

There are no Buy or Sell transactions made by insiders since 9/12/2023

Armata Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Deborah Birx Chief Executive Officer, Director $1.3M Mar 14, 2024
Richard Rychlik Corporate Controller and PFO $50K Mar 14, 2024
Pierre Kyme Chief Business Officer $50K Jun 19, 2024
Sarah Schlesinger Director Mar 14, 2024
Todd Patrick Director Apr 13, 2022
Joseph M. Patti Director Mar 14, 2024
Kostas D. Odysseas Director Mar 14, 2024
Jules Haimovitz Director Mar 14, 2024
Duane Alfred Morris VP of Operations Apr 13, 2022
Brian Varnum President and CEO Apr 13, 2022
Robin Kramer Director Mar 14, 2024
Todd C. Peterson Director Mar 14, 2024
Julianne Averill Chief Financial Officer May 2, 2023
Erin Butler Vice President,Finance & Admin Jul 1, 2022
David D. House SVP, Finance, and PFO Aug 16, 2024
Innoviva, Inc. Director, 10%+ Owner Jan 10, 2023

Recent Insider Transactions by Companies or Individuals for Armata Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.